V. Thibault

J. Gauldie, V. Thibault, B. Terlain, 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjögren’s syndrome

D. Sène, P. Cacoub, V. Thibault, 2006, Annals of the rheumatic diseases.

A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study

B. Gagnière, D. Costagliola, P. Fillâtre, 2021, Clinical Microbiology and Infection.

Construction and Characterization of a Replication-Deficient Adenovirus Expressing Rat-Soluble Interleukin-6 Receptor

F. Graham, J. Gauldie, V. Thibault, 1997, Molecular medicine.

Multicenter Quality Control for the Detection of Hepatitis C Virus RNA in Seminal Plasma Specimens

J. Pawlotsky, C. Rouzioux, S. Laporte, 2003, Journal of Clinical Microbiology.

Serum CXCL 10 , CXCL 11 , CXCL 12 , and CXCL 14 chemokine patterns in patients with acute liver injury

V. Thibault, M. Samson, C. Pronier, 2019 .

Serum CXCL10, CXCL11, CXCL12, and CXCL14 chemokine patterns in patients with acute liver injury

V. Thibault, M. Samson, V. Carrière, 2018, Cytokine.

Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia

J. Piette, L. Musset, J. Huraux, 1998, Annals of the rheumatic diseases.

Comparative Analysis of Translation Efficiencies of Hepatitis C Virus 5′ Untranslated Regions among Intraindividual Quasispecies Present in Chronic Infection: Opposite Behaviors Depending on Cell Type

J. Toulmé, H. Agut, J. Pawlotsky, 2000, Journal of Virology.

Successful heart transplantation for COVID‐19‐associated post‐infectious fulminant myocarditis

M. Lederlin, G. Leurent, N. Nesseler, 2021, ESC heart failure.

European multicenter evaluation of Xpert® Xpress SARS‐CoV‐2/Flu/RSV test

W. Melchers, H. Kessler, V. Thibault, 2021, Journal of medical virology.

Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection.

J. Piette, F. Davi, H. Merle-Béral, 2004, Arthritis and rheumatism.

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

M. Vidaud, J. Huraux, T. Poynard, 1998, Hepatology.

Incidence and characteristics of nosocomial influenza in a country with low vaccine coverage.

V. Thibault, P. Tattevin, S. Jouneau, 2020, The Journal of hospital infection.

Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case–control study

L. Misery, E. Oger, A. Dupuy, 2021, Clinical Microbiology and Infection.

Antibodies to rat soluble IL‐6 receptor stimulate B9 hybridoma cell proliferation

J. Gauldie, V. Thibault, C. Richards, 1997, FEBS letters.

Lateral rectus muscle paralysis induced by ribavirin and pegylated interferon-α2a in a patient with HIV/HCV co-infection

R. Tubiana, V. Thibault, M. Valantin, 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay.

X. de Lamballerie, P. Marcellin, J. Pawlotsky, 2000, Journal of virological methods.

The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C

T. Poynard, R. Myers, V. Thibault, 2003, Journal of viral hepatitis.

Six-Year Follow-Up of Hepatitis B Surface Antigen Concentrations in Tenofovir Disoproxil Fumarate Treated HIV–Hbv-Coinfected Patients

R. Tubiana, C. Katlama, V. Thibault, 2011, Antiviral therapy.

Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.

Y. Sterkers, P. Cacoub, P. Halfon, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Impact of hepatitis B virus genotypes and surface antigen variants on the performance of HBV real time PCR quantification.

V. Thibault, A. Roque-Afonso, S. Laperche, 2009, Journal of virological methods.

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis Delta.

F. Roudot-thoraval, F. Zoulim, D. Roulot, 2020, Journal of hepatology.

Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).

V. de Lédinghen, E. Schiff, Y. Ngo, 2014, Journal of hepatology.

Role of non-aerosols activities in the transmission of SARS-Cov-2 infection among health care workers.

Cécile Paris, P. Wild, R. Garlantézec, 2021, medRxiv.

Risk factors for SARS-CoV-2 infection among health care workers

P. Wild, R. Garlantézec, V. Thibault, 2021, American Journal of Infection Control.

H. Agut, B. Bauvois, A. Cahour, 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A lateral flow immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers

R. Garlantézec, V. Thibault, P. Tattevin, 2020, Emerging microbes & infections.

[Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia].

T. Maisonobe, P. Cacoub, V. Thibault, 2001, La Revue de medecine interne.

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021

C. Charpentier, S. Cauchemez, J. Pawlotsky, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

O. Decaux, S. Pol, L. Musset, 2015, Journal of hepatology.

Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.

J. Piette, P. Cacoub, D. Saadoun, 2006, Arthritis and rheumatism.

Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune‐Mediated Inflammatory Diseases

D. Thabut, F. Berenbaum, S. Pol, 2013, Arthritis care & research.

Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study

N. Schnepf, P. Colson, P. Trimoulet, 2013, Virology Journal.

Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.

V. Calvez, T. Poynard, V. Thibault, 2006, Journal of hepatology.

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

V. Calvez, T. Poynard, V. Thibault, 2001, The Lancet.

Where does adefovir stand amongst newly developed antivirals: from pharmacology to virology

V. Thibault, 2006 .

Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant

T. Poynard, V. Ratziu, V. Thibault, 2006, Comparative Hepatology.

57 Long-term incidence of adefovir dipivoxil (ADV) resistance in chronic hepatitis B (CHB) patients after 144 weeks of therapy

C. Gibbs, V. Thibault, S. Arterburn, 2004 .

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

J. Izopet, D. Roulot, P. Colson, 2009, Journal of medical virology.

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity

S. Bertrais, S. Castelain, B. Roquebert, 2016, Journal of gastroenterology and hepatology.

Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus.

J. Piette, D. Sène, L. Musset, 2004, The Journal of rheumatology.

Hepatitis C virus infection in systemic lupus erythematosus: a case-control study.

J. Piette, G. Perlemuter, P. Cacoub, 2003, The Journal of rheumatology.

Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia

T. Maisonobe, P. Cacoub, V. Thibault, 2001, Annals of the rheumatic diseases.

Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients

C. Katlama, E. Caumes, G. Pialoux, 2006, AIDS.

Acute hepatitis C in HIV‐infected men who have sex with men

R. Tubiana, C. Katlama, E. Caumes, 2004, HIV medicine.

Sexually transmitted hepatitis C virus superinfection in HIV/hepatitis C virus co-infected men who have sex with men

C. Delaugerre, C. Rouzioux, S. Pol, 2008, AIDS.

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

M. Vidaud, J. Huraux, T. Poynard, 1998, Hepatology.

Hepatitis C virus infection in long-term nonprogressor HIV-1-infected subjects.

H. Agut, B. Autran, A. Cahour, 2002, Journal of acquired immune deficiency syndromes.

SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France

R. Garlantézec, V. Thibault, P. Tattevin, 2022, Infectious Diseases Now.

Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.

F. Carrat, D. Klatzmann, F. Joly, 2011, The New England journal of medicine.

Interleukin 2 treatment does not modify hepatitis B or C replication in human immunodeficiency virus–infected patients: Results from a randomized control trial

V. Calvez, R. Tubiana, C. Delaugerre, 2002, Hepatology.

Characterization of a New Sensitive PCR Assay for Quantification of Viral DNA Isolated from Patients with Hepatitis B Virus Infections

F. Zoulim, V. Thibault, Jane B Smith, 2007, Journal of Clinical Microbiology.

Unusual Selection of Rta181V Hbv Mutants Cross-Resistant to Adefovir following Prolonged Lamivudine Monotherapy: Report of Two Cases

P. Colson, C. Tamalet, D. Botta, 2005, Antiviral therapy.

Resistance surveillance of HBEAG— chronic hepatitis B (CHB) patients treated for two years with adefovir dipivoxil (ADV)

M. Wulfsohn, C. Gibbs, P. Angus, 2003 .

1158 Long term treatment with adefovir dipivoxil (ADV) for three years in patients with lamivudine-resistant (LAM-R) HBV and HIV co-infection results in significant and sustained clinical improvement

C. Katlama, T. Poynard, V. Thibault, 2003 .

1164 susceptibility of wild-type and lamivudine-resistant hepatitis B virus to tenofovir and adefovir

C. Katlama, A. Cahour, T. Poynard, 2003 .

Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Resistance Mutations in Hepatitis B Virus (HBV)-HIV-Coinfected Patients Treated for HBV Chronic Infection Once Daily with 10 Milligrams of Adefovir Dipivoxil Combined with Lamivudine

V. Calvez, C. Delaugerre, C. Katlama, 2002, Antimicrobial Agents and Chemotherapy.

Safety and efficacy of long-term adefovir dipivoxil (ADV) for lamivudine-resistant (LAM-R) HBV in HIV infected patients

V. Calvez, C. Katlama, T. Poynard, 2002 .

Hepatitis B Virus (HBV) Mutations Associated with Resistance to Lamivudine in Patients Coinfected with HBV and Human Immunodeficiency Virus

H. Agut, C. Katlama, T. Poynard, 1999, Journal of Clinical Microbiology.

Unsuccessful rescue therapy with adefovir dipivoxil for lamivudine resistant HBV in a patient with liver failure

D. Thabut, T. Poynard, V. Ratziu, 2003, Gut.

Tenofovir disoproxil fumarate (TDF) suppresses lamivudine-resistant HBV replication in patients co-infected with HIV/HBV

R. Tubiana, C. Katlama, J. Rooney, 2002, Journal of Hepatology.

Efficacy and Safety of Adefovir Dipivoxil plus Pegylated Interferon-α2a for the Treatment of Lamivudine-Resistant Hepatitis B virus Infection in HIV-Infected Patients

C. Katlama, T. Poynard, V. Thibault, 2008, Antiviral Therapy.

Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

C. Katlama, T. Poynard, V. Thibault, 2008, Antiviral therapy.

Efficacy and safety of adefovir dipivoxil plus pegylated interferon-α 2 a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients

C. Katlama, T. Poynard, V. Thibault, 2022 .

Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient.

D. Thabut, T. Poynard, B. Bernard, 2001, AIDS.

Primary infection with a lamivudine-resistant hepatitis B virus.

H. Agut, C. Katlama, V. Thibault, 2002, AIDS.

Impact of hepatitis B and C virus on kidney transplantation outcome

P Coriat, P. Coriat, C. Fretz, 1999, Hepatology.

Molecular Epidemiology and Clinical Characteristics of Hepatitis B Identified through the French Mandatory Notification System

E. Delarocque-Astagneau, V. Thibault, S. Laperche, 2013, PloS one.

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.

T. Poynard, V. Ratziu, R. Myers, 2003, Journal of hepatology.

Resistance profile of adefovir dipivoxil (ADV) in immunocompetent and immunocompromised chronic hepatitis B patients after 48 weeks of adefovir dipivoxil therapy

M. Wulfsohn, C. Gibbs, Huiling Yang, 2003 .

Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B

D. Thabut, T. Poynard, P. Opolon, 2004, European journal of gastroenterology & hepatology.

Chronic hepatitis B treatment with lamivudine in kidney transplant patients.

P. Coriat, T. Poynard, P. Opolon, 2000, Transplantation proceedings.

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

C. Katlama, T. Poynard, V. Ratziu, 2003, AIDS.

Factors affecting liver fibrosis in human immunodeficiency virus–and hepatitis C virus–coinfected patients: Impact of protease inhibitor therapy

C. Katlama, T. Poynard, V. Thibault, 2001, Hepatology.

Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples.

V. Thibault, A. Roque-Afonso, S. Laperche, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study

N. Schnepf, P. Colson, P. Trimoulet, 2013, Virology Journal.

[Development and validation of a specific method for relative HBV-genotype G (G-HBV) quantification in the context of co-infection with other genotypes].

C. Katlama, V. Thibault, F. Ben Moussa, 2011, Pathologie et biologie.

Coexistence of Hepatitis B Surface Antigen (HBs Ag) and Anti-HBs Antibodies in Chronic Hepatitis B Virus Carriers: Influence of “a” Determinant Variants

T. Poynard, V. Thibault, Y. Benhamou, 2006, Journal of Virology.

Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification.

Y. Ngo, T. Poynard, V. Thibault, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Molecular analysis of HBV genotypes and subgenotypes in the Central-East region of Tunisia

J. Gharbi, O. Bahri, H. Triki, 2010, Virology Journal.

A Highly Prevalent Polymorphism in the Core Region Impairs Quantification of Hepatitis B Virus (HBV) by the cobas TaqMan HBV Assay

S. Chevaliez, V. Thibault, S. Laperche, 2020, Journal of Clinical Microbiology.

Definition of an HBsAg to DNA international unit conversion factor by enrichment of circulating hepatitis B virus forms

Y. Ngo, J. Vaillant, T. Poynard, 2015, Journal of viral hepatitis.

More on HBe Ag-negative mutants in chronic HBV infection.

H. Agut, J. Huraux, V. Thibault, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria].

V. Thibault, F. Khelifa, 2009, Pathologie-biologie.

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study

P. Couzigou, P. Marcellin, J. Pawlotsky, 2005, Journal of viral hepatitis.

Combined use of dried blood spot and rapid molecular systems: a robust solution to monitor hepatitis B virus infection with potential for resource-limited countries.

V. Thibault, C. Pronier, C. Heslan, 2020, Journal of virological methods.

Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.

C. Katlama, S. Demeret, V. Mallet, 2017, AIDS.

Could Droplet Digital PCR Be Used Instead of Real-Time PCR for Quantitative Detection of the Hepatitis B Virus Genome in Plasma?

V. Thibault, S. Laperche, N. Désiré, 2014, Journal of Clinical Microbiology.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

J. Pawlotsky, H. Fleury, G. Duverlie, 2015, Journal of Clinical Microbiology.

An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

Y. Ngo, D. Thabut, T. Poynard, 2008, PloS one.

Comparison of Hepatitis C Virus NS5b and 5′ Noncoding Gene Sequencing Methods in a Multicenter Study

J. Pawlotsky, G. Duverlie, J. Izopet, 2005, Journal of Clinical Microbiology.

Genotype 4 hepatitis C virus: Beware of false‐negative RNA detection

V. Thibault, S. Laperche, S. Akhavan, 2011, Hepatology.

Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort

Y. Yazdanpanah, J. Timsit, F. Raffi, 2021, Proceedings of the National Academy of Sciences.

Natural variability of NS3 protease in patients infected with genotype 4 hepatitis C virus (HCV): implications for antiviral treatment using specifically targeted antiviral therapy for HCV.

T. Poynard, P. Lebray, V. Thibault, 2009, The Journal of infectious diseases.

Biphasic evolution of varicella-zoster virus meningoencephalitis : Diagnostic challenges.

V. Thibault, P. Tattevin, F. Reizine, 2019, Medecine et maladies infectieuses.

Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases.

P. Marcellin, C. Bréchot, S. Pol, 2000, Journal of hepatology.

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.

M. Van Ranst, J. Izopet, D. Roulot, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma

P. André, J. Pawlotsky, J. Izopet, 2017, PloS one.

Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategy

F. Carrat, S. Pol, H. Fontaine, 2019, Journal of viral hepatitis.

Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategy

F. Carrat, S. Pol, H. Fontaine, 2018, Journal of viral hepatitis.

Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study

T. Asselah, F. Zoulim, D. Ouzan, 2017, European journal of gastroenterology & hepatology.

HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcome.

R. Tubiana, C. Katlama, J. Golmard, 2010, Fertility and sterility.

Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.

P. André, J. Pawlotsky, S. Bertrais, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Contribution of quantitative viral markers to document hepatitis B virus compartmentalization in cerebrospinal fluid during hepatitis B with neuropathies

D. Guyader, V. Thibault, P. Tattevin, 2018, Journal of NeuroVirology.

Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

J. Piette, T. Maisonobe, P. Cacoub, 2002, Arthritis and rheumatism.

A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality

B. Gagnière, D. Costagliola, P. Fillâtre, 2021, medRxiv.

Adjustment of antiretroviral regimen may lead to HBV reactivation even in patients with past HBV infection serological profile

C. Katlama, V. Thibault, M. Valantin, 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Herpesviridae systemic reactivation in patients with COVID-19-associated ARDS

J. Tadié, A. Gacouin, V. Thibault, 2021, Journal of Hospital Infection.

Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders

D. Sène, P. Cacoub, D. Saadoun, 2008, Annals of the rheumatic diseases.

Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease.

J. Piette, S. Pol, C. Renou, 2002, The Journal of infectious diseases.

Improving the screening of precancerous anal lesions in high-risk subjects with normal cytology: A longitudinal cohort study using simple tests.

A. Lièvre, C. Brochard, L. Siproudhis, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV–hepatitis C virus co-infection

C. Katlama, B. Autran, T. Poynard, 2003, AIDS.

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.

Christine Katlama, Dominique Thabut, Y. Ngo, 2013, Journal of hepatology.

Liver fibrosis in overweight patients.

P. Giral, E. Bruckert, T. Poynard, 2000, Gastroenterology.

Hepatitis C virus infection in cutaneous polyarteritis nodosa: a retrospective study of 16 cases.

J. Piette, J. Roujeau, P. Wolkenstein, 1999, Archives of dermatology.

HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C.

Y. Ngo, T. Poynard, V. Ratziu, 2011, Clinics and research in hepatology and gastroenterology.

Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred.

M. Rudler, D. Thabut, D. Bonnefont-Rousselot, 2010, Journal of hepatology.

Renal microaneurysms in three cases of hepatitis C virus-related vasculitis.

P. Cluzel, T. Maisonobe, Z. Amoura, 2002, Rheumatology.

Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles

P. Gripon, V. Thibault, S. Laperche, 2022, PloS one.

Acute hepatitis B virus infection despite vaccination in a patient treated by infliximab: a case report

G. Bouguen, D. Guyader, V. Thibault, 2022, BMC Gastroenterology.

Performances of NeuMoDx™, a random-access system for HBV-DNA and HCV-RNA quantification.

V. Thibault, A. Maillard, C. Pronier, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Performances of NeuMoDx, a random-access system for HBV-DNA and HCV-RNA quantification

V. Thibault, A. Maillard, C. Pronier, 2020, bioRxiv.

The contribution of more sensitive hepatitis B surface antigen assays to detecting and monitoring hepatitis B infection.

D. Candotti, V. Thibault, S. Laperche, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[Viral markers of hepatitis B, C and D and HB vaccination status of a health care team in a rural district of Cameroon].

J. Huraux, F. Lunel, V. Thibault, 2011, Medecine tropicale : revue du Corps de sante colonial.

Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study

J. Tadié, A. Gacouin, Y. le Tulzo, 2020, ERJ Open Research.

Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data

R. Garlantézec, V. Thibault, P. Tattevin, 2021, Clinical Microbiology and Infection.

Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers

R. Garlantézec, V. Thibault, P. Tattevin, 2022, Vaccine.

Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms.

J. Tadié, A. Gacouin, Y. le Tulzo, 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

Y. Ngo, D. Thabut, T. Poynard, 2006, Clinical chemistry.

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

D. Thabut, T. Poynard, V. Ratziu, 2004, Clinical chemistry.

Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study

P. Vanhems, F. Carrat, P. Dieudé, 2020, Infection.

Potential exposure to hepatitis C virus through accidental blood contact in interventional radiology.

P. Cluzel, P. Legmann, A. Denys, 2003, Journal of vascular and interventional radiology : JVIR.

Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study

P. Vanhems, E. Casalino, L. Argaud, 2022, Scientific Reports.

Using Discarded Facial Tissues to Monitor and Diagnose Viral Respiratory Infections

V. Thibault, A. Maillard, P. Comacle, 2023, Emerging infectious diseases.

Too Often Forgotten: Passive Transfer of Antibodies.

V. Thibault, J. Léger, L. Pinte, 2016, Clinical Infectious Diseases.

Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection.

A. Samri, B. Autran, M. Guiguet, 2012, Journal of hepatology.

Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24

O. Decaux, S. Pol, L. Musset, 2013, Annals of the rheumatic diseases.

Serum biochemical markers of liver fibrosis in human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-coinfected patients

C. Katlama, T. Poynard, V. Ratziu, 2002 .

Noninvasive prediction of fibrosis in patients with chronic hepatitis C

D. Thabut, T. Poynard, R. Myers, 2003, Hepatology.

TaqMan amplification system with an internal positive control for HCV RNA quantitation.

G. Duverlie, D. Bonte, C. François, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Genetic heterogeneity of the hypervariable region I of Hepatitis C virus and lymphoproliferative disorders

F. Davi, P. Cacoub, A. Cahour, 2005, Leukemia.

Efficient and Quality-Optimized Metagenomic Pipeline Designed for Taxonomic Classification in Routine Microbiological Clinical Tests

G. Rizk, V. Thibault, V. Cattoir, 2022, Microorganisms.

When a viral eruption hides another one: intrafamilial outbreak of parvovirus B19 and measles virus co-infections: case report

V. Thibault, P. Tattevin, A. Vabret, 2020, BMC Infectious Diseases.

COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020

F. Lemaitre, V. Thibault, P. Tattevin, 2020, Emerging Infectious Diseases.

Expertise of French Laboratories in Detection, Genotyping, and Quantification of Hepatitis C Virus RNA in Serum

J. Pawlotsky, F. Roudot-thoraval, J. Izopet, 2004, Journal of Clinical Microbiology.

Changing Electrolyte and Acido-Basic Profile in HIV-Infected Patients in the HAART Era

S. Tezenas du Montcel, G. Carcelain, C. Katlama, 2006, Nephron Physiology.

Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study

P. Marcellin, G. Duverlie, P. Trimoulet, 2019, Epidemiology and Infection.

Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening?

M. Rudler, D. Thabut, T. Poynard, 2015, European journal of gastroenterology & hepatology.

Interpretation of Real-Time PCR Results for Hepatitis C Virus RNA When Viral Load Is Below Quantification Limits

J. Pawlotsky, G. Duverlie, J. Izopet, 2011, Journal of Clinical Microbiology.

Early Detection of Hepatitis C Virus Infection by Use of a New Combined Antigen-Antibody Detection Assay: Potential Use for High-Risk Individuals

R. Tubiana, C. Katlama, V. Thibault, 2006, Journal of Clinical Microbiology.

Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus

B. Autran, V. Thibault, V. Di Martino, 2002, AIDS.

Contribution of quantitative viral markers to document hepatitis B virus compartmentalization in cerebrospinal fluid during hepatitis B with neuropathies

D. Guyader, V. Thibault, P. Tattevin, 2018, Journal of NeuroVirology.

Performance comparison of new Veris and Xpert random access HIV-1 RNA quantification assays

V. Thibault, A. Maillard, C. Pronier, 2018, Virology Journal.

Characterization of hepatitis B viral forms from patient plasma using velocity gradient: evidence for an excess of capsids in Dane particles enriched fractions

P. Gripon, V. Thibault, S. Laperche, 2022, bioRxiv.

224 INTEREST OF FIBROTEST-ACTITEST (FT-AT) IN THE FOLLOW-UP OF LIVER TRANSPLANTED (LT) PATIENTS: A PILOT STUDY

B. Hainque, T. Poynard, M. Munteanu, 2008 .

Genotype 4 hepatitis C virus: Beware of false‐negative RNA detection

V. Thibault, S. Laperche, S. Akhavan, 2011, Hepatology.

[Interleukin-1 and regulation of glucose homeostasis].

V. Thibault, B. Terlain, O. Ekindjian, 1993, Pathologie-biologie.